News
Elinzanetant is the first neurokinin-targeted therapy to demonstrate efficacy in reducing vasomotor symptoms (VMS)” — ...
During a live event, Heather L. McArthur, MD, MPH, discussed the TAILORx trial in node-negative hormone ...
Thousands of women with advanced breast cancer could be denied life-extending drugs because of the “unfair” way they are ...
AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...
Datroway is used to treat an advanced form of non-small cell lung cancer in adults who had received prior treatment.
21h
Oxford Mail on MSNOxfordshire breast cancer patient 'missing out' on life-saving drugsA mum from Banbury with breast cancer said a life-extending drug would be 'worth it', as a charity speaks out on the 'unfair' ...
FDA grants accelerated approval to AstraZeneca's Datroway for EGFR-mutant NSCLC after prior therapies, with a 45% response ...
Just days after President Donald Trump was elected in November, AstraZeneca unvei | AstraZeneca CEO Pascal Soriot is plotting ...
Research presented at the ASCO Annual Meeting 2025 highlighted new potential standards of care and other advances in breast cancer.
In this video, Megan Kruse, MD, breast medical oncologist at Cleveland Clinic, discusses results from the SERENA-6 trial, ...
8d
Zacks Investment Research on MSNFDA Grants Label Expansion to AstraZeneca's Datroway in Lung CancerAstraZeneca AZN announced that the FDA has expanded the label of its cancer drug Datroway for a second indication — non-small ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results